| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | Chief Financial Officer | Common Stock, par value $0.001 | 1,248,604 | $1,634,422 | $1.31 | 01 Oct 2025 | Direct |
| AVENUE THERAPEUTICS, INC. | Interim PFO and COO | COMMON STOCK, PAR VALUE $0.0001 | 65,000 | $9,100 | $0.1400 | 23 Sep 2024 | Direct |
| MUSTANG BIO, INC. | Director | COMMON STOCK, PAR VALUE $0.0001 | 286 | $275 | $0.9620 | 30 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MBIO | MUSTANG BIO, INC. | 30 Dec 2025 | 1 | +$238 | 4 | Director | 30 Dec 2025, 16:15 |
| FBIO | Fortress Biotech, Inc. | 01 Oct 2025 | 1 | +$3,549 | 4 | Chief Financial Officer | 02 Oct 2025, 16:30 |
| FBIO | Fortress Biotech, Inc. | 01 Apr 2025 | 1 | +$6,078 | 4 | Chief Financial Officer | 01 Apr 2025, 16:20 |
| FBIO | Fortress Biotech, Inc. | 19 Dec 2024 | 1 | $0 | 4 | Chief Financial Officer | 23 Dec 2024, 16:30 |
| MBIO | MUSTANG BIO, INC. | 23 Oct 2024 | 0 | $0 | 3 | Director | 29 Oct 2024, 16:05 |
| FBIO | Fortress Biotech, Inc. | 01 Oct 2024 | 1 | +$3,224 | 4 | Chief Financial Officer | 01 Oct 2024, 16:15 |
| ATXI | AVENUE THERAPEUTICS, INC. | 23 Sep 2024 | 1 | $0 | 4 | Interim PFO and COO | 25 Sep 2024, 16:53 |
| FBIO | Fortress Biotech, Inc. | 10 Jul 2024 | 1 | +$3,750 | 4 | Chief Financial Officer | 12 Jul 2024, 08:42 |
| FBIO | Fortress Biotech, Inc. | 01 Apr 2024 | 1 | +$3,998 | 4 | Chief Financial Officer | 02 Apr 2024, 16:06 |
| FBIO | Fortress Biotech, Inc. | 20 Dec 2023 | 1 | $0 | 4 | Chief Financial Officer | 22 Dec 2023, 16:05 |
| ATXI | AVENUE THERAPEUTICS, INC. | 30 Jun 2023 | 1 | $0 | 4 | Interim PFO and COO | 05 Jul 2023, 16:09 |
| FBIO | Fortress Biotech, Inc. | 10 Feb 2023 | 1 | +$30,000 | 4 | Chief Financial Officer | 14 Feb 2023, 15:06 |
| FBIO | Fortress Biotech, Inc. | 30 Nov 2022 | 1 | +$2,800 | 4 | Chief Financial Officer | 02 Dec 2022, 15:14 |
| FBIO | Fortress Biotech, Inc. | 26 Oct 2022 | 1 | $0 | 4 | Chief Financial Officer | 28 Oct 2022, 17:02 |
| FBIO | Fortress Biotech, Inc. | 16 Aug 2022 | 0 | $0 | 3 | Chief Financial Officer | 25 Aug 2022, 16:02 |
| ATXI | AVENUE THERAPEUTICS, INC. | 11 May 2022 | 0 | $0 | 3 | Int. PEO, Int. PFO, and COO | 25 May 2022, 16:05 |